KEYNOTE: The Global Shift in Clinical Trial Sites: What the Data Reveals and What It Means for You

Session details:

New data from Tufts CSDD reveals dramatic changes in the global investigative site landscape. In recent years, the share of U.S.-based sites participating in active global clinical trials has declined sharply, while sites in Asia have gained ground. At the same time, part‑time, community‑based sites—particularly in the U.S.—are steadily losing share as large, private equity‑backed site networks rapidly expand. 

This session presents evidence of these structural shifts and examines their implications for sites, sponsors, CROs, and academic research centers, including potential market and regulatory responses as the industry adapts to an evolving global landscape.